Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$853,059
-$48,437 QoQ
Shares Held
3,390
-18.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#2,698
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Voya Financial Advisors, Inc. holds $8,834,039 across 10 Drug Manufacturers - General names. ABBV ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
31,519 | $1,652,225 | |
| 2 | NVS |
Novartis AG
|
10,020 | $1,570,334 | |
| 3 | AMGN |
Amgen Inc
|
3,137 | $1,135,970 | |
| 4 | LLY |
ELI LILLY & Co
|
805 | $965,541 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,390 | $853,059 | |
| 6 | PFE |
Pfizer Inc
|
34,853 | $839,260 | |
| 7 | SNY |
Sanofi
|
14,392 | $613,962 | |
| 8 | JNJ |
Johnson & Johnson
|
1,866 | $473,908 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $853,059 | 3,390 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $901,496 | 4,145 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,046,255 | 4,579 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,150,059 | 4,967 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $993,067 | 5,350 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $843,108 | 4,024 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $904,315 | 5,089 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $857,853 | 4,344 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $620,902 | 3,620 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $652,646 | 3,584 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $643,900 | 4,155 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $605,332 | 4,061 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $565,596 | 4,198 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $697,721 | 4,378 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $715,932 | 4,430 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $558,850 | 4,164 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $630,406 | 4,116 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $690,102 | 4,257 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $787,080 | 5,813 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $591,990 | 5,488 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $590,120 | 5,239 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,101,057 | 47,136 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,047,515 | 47,107 | Shares | Defined | 2021-03-05 | |
| 2020-09-30 | $3,920,353 | 44,758 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,967,318 | 50,594 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,420,772 | 58,023 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||